MiNK Therapeutics, Inc.INKTNASDAQ
Loading
Year-over-year free cash flow growth rate
| Period | Value |
|---|---|
| Q3 2025 | 40.01% |
| Q2 2025 | 99.88% |
| Q1 2025 | -77511.95% |
| Q4 2024 | 42.31% |
| Q3 2024 | -30.74% |
| Q2 2024 | 9.89% |
| Q1 2024 | 16.26% |
| Q4 2023 | 28.27% |
| Q3 2023 | -1.05% |
| Q2 2023 | 4.38% |
| Q1 2023 | 3.91% |
| Q4 2022 | 19.67% |
| Q3 2022 | -21.06% |
| Q2 2022 | -11.70% |
| Q1 2022 | -146.56% |
| Q4 2021 | 52.82% |
| Q3 2021 | -2.55% |
| Q2 2021 | 17.19% |
| Q1 2021 | -147.32% |
| Q4 2020 | 33.48% |
| Q3 2020 | -24.97% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |